Insider Trading Activity Merck & Co. (NYSE:MRK) – EVP Sold 9,972 shares of Stock

ME Staff
-
0

Insider Trading Activity For Merck & Co. (NYSE:MRK)

Julie L. Gerberding , EVP of Merck & Co. (NYSE:MRK) reportedly Sold 9,972 shares of the company’s stock at an average price of 59.66 for a total transaction amount of $594,929.52 SEC Form

Insider Trading History For Merck & Co. (NYSE:MRK)

  • On 8/9/2012 Willie A Deese, Insider, sold 62,324 with an average share price of $44.26 per share and the total transaction amounting to $2,758,460.24.
  • On 5/13/2013 Bridgette P Heller, VP, sold 5,404 with an average share price of $46.15 per share and the total transaction amounting to $249,394.60.
  • On 5/15/2013 Adele D Ambrose, Insider, sold 34,208 with an average share price of $46.66 per share and the total transaction amounting to $1,596,145.28.
  • On 8/7/2013 Willie Deese, Insider, sold 50,638 with an average share price of $48.55 per share and the total transaction amounting to $2,458,474.90.
  • On 2/10/2014 Willie Deese, Insider, sold 50,000 with an average share price of $54.68 per share and the total transaction amounting to $2,734,000.00.
  • On 2/10/2014 Peter Wendell, Director, sold 5,000 with an average share price of $54.44 per share and the total transaction amounting to $272,200.00.
  • On 2/11/2014 Kenneth Frazier, CEO, sold 41,520 with an average share price of $54.52 per share and the total transaction amounting to $2,263,670.40.

    • Analyst Ratings History For Merck & Co. (NYSE:MRK)

    • On 10/27/2016 Argus Reiterated Rating Buy with a price target of $65.00 ➝ $80.00
    • On 1/12/2017 Guggenheim Upgraded rating Neutral ➝ Buy with a price target of $61.63 ➝ $70.00
    • On 1/13/2017 Bryan, Garnier & Co Initiated Coverage of rating Buy
    • On 7/29/2017 Piper Jaffray Set Price Target of rating Buy with a price target of $70.00
    • On 10/29/2017 JPMorgan Chase Set Price Target of rating Buy with a price target of $70.00
    • On 10/30/2017 UBS Lower Price Target of rating Buy with a price target of $72.00 ➝ $67.00
    • On 10/30/2017 Citigroup Upgraded rating Buy

    Dividend Information For Merck & Co. (NYSE:MRK)
    Merck & Co. (NYSE:MRK) pays an annual dividend of $1.92 with a yield of 3.21% and an average dividend growth of 2.20% (3 Year Average).

    Dividend History For Merck & Co. (NYSE:MRK)

  • On 2/26/2013 Merck & Co. announced a quarterly dividend of $0.43 4% with an ex dividend date of 3/13/2013 which will be payable on 4/5/2013.
  • On 5/28/2013 Merck & Co. announced a quarterly dividend of $0.43 3.67% with an ex dividend date of 6/13/2013 which will be payable on 7/8/2013.
  • On 7/24/2013 Merck & Co. announced a quarterly dividend of $0.43 3.57% with an ex dividend date of 9/12/2013 which will be payable on 10/7/2013.
  • On 11/26/2013 Merck & Co. announced a quarterly dividend of $0.44 3.53% with an ex dividend date of 12/12/2013 which will be payable on 1/8/2014.
  • On 2/25/2014 Merck & Co. announced a quarterly dividend of $0.44 3.13% with an ex dividend date of 3/13/2014 which will be payable on 4/7/2014.
  • On 5/27/2014 Merck & Co. announced a quarterly dividend of $0.44 3.12% with an ex dividend date of 6/12/2014 which will be payable on 7/8/2014.
  • On 7/23/2014 Merck & Co. announced a quarterly dividend of $0.44 3.02% with an ex dividend date of 9/11/2014 which will be payable on 10/7/2014.

    • Recent Trading Activity for Merck & Co. (NYSE:MRK)
    Shares of Merck & Co. closed the previous trading session at 59.77 up +0.59 1.00% with 59.31999969482422 shares trading hands.